Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

pegylated deoxycytidine analogue DFP-14927

A pegylated formulation containing DFP-10917, an analogue of the nucleoside deoxycytidine, with potential antineoplastic activity. Upon administration, the pegylated deoxycytidine analogue DFP-14927 is incorporated into the DNA of rapidly proliferating cells, such as tumor cells, and directly inhibits the activity of DNA polymerase, which results in the inhibition of DNA replication and cell cycle arrest, DNA fragmentation, and tumor cell apoptosis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	PEGylated DFP-10917 polymeric nucleoside analogue DFP-14927
Code name:	DFP 14927 DFP-14927 DFP14927

pegylated deoxycytidine analogue DFP-14927

Search NCI's Drug Dictionary